Skip to main content

INDV 6-K

Indivior Pharmaceuticals, Inc. (INDV)

6-K 2024-09-10 For: 2024-09-10
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

________________________

Washington, D.C. 20549

_____________________

FORM 6-K

_____________________

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of September 2024

Commission File Number: 001-37835

________________________________________

Indivior PLC

________________________________________

10710 Midlothian Turnpike, Suite 125

North Chesterfield, Virginia 23235

(Address of principal executive office)

_______________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit<br>No. Description<br>of Exhibit
99.1 Announcement sent<br>to the London Stock Exchange on September 10, 2024, titled<br>“Transaction in Own Shares”.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Indivior PLC
Date: September 10, 2024 /s/<br>Kathryn Hudson
Name:<br>Kathryn Hudson
Title:<br>Company Secretary

indiviorplc

Exhibit 99.1

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

September 10, 2024

INDIVIOR PLC (“Indivior”) announces that it purchased for cancellation a total of 433,485 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 2, 2024, up to and including September 6, 2024, in connection with its $100m Share Repurchase Program. Aggregated information on the purchase of these shares can be found in the table below.

Following the purchase and cancellation of the above shares (including those purchased but not yet settled), Indivior has 131,025,839 ordinary shares of $0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (131,025,839) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA’s Disclosure Guidance and Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Aggregated information

Trading<br>Date Trading<br>Venue Aggregated<br>daily volume (number of shares) Daily<br>weighted average purchase price of the shares (p)
02/09/2024 LSE 37,116 930.99
02/09/2024 BATE 10,866 925.40
02/09/2024 CHIX 25,474 927.99
02/09/2024 AQUIS 3,942 928.29
03/09/2024 LSE 33,774 928.13
03/09/2024 BATE 10,656 931.97
03/09/2024 CHIX 28,498 930.73
03/09/2024 AQUIS 4,808 931.72
04/09/2024 LSE 33,844 902.26
04/09/2024 BATE 13,845 903.46
04/09/2024 CHIX 27,357 901.23
04/09/2024 AQUIS 4,663 904.49
05/09/2024 LSE 36,019 932.19
05/09/2024 BATE 12,209 928.06
05/09/2024 CHIX 27,457 930.59
05/09/2024 AQUIS 4,143 929.09
06/09/2024 LSE 55,679 810.31
06/09/2024 BATE 28,468 810.54
06/09/2024 CHIX 28,398 803.35
06/09/2024 AQUIS 6,269 801.88

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley & Co. International Plc on behalf of Indivior during the above period as part of the Share Repurchase Program can be found at www.indivior.com/en/investors/shareholder-information/share-repurchase-program.

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123